Sieger Therapeutics Private Limited - Company Profile

It is a business services private limited company based in Dwarka, Delhi, India, established in 2018.
2018 Dwarka, Delhi, India Struck Off
Last Updated:
About Sieger Therapeutics Private Limited

Sieger Therapeutics Private Limited, a struck off private limited company, was established on 05 January 2018 in Dwarka, Delhi, India. Engaging in other services within the business services sector, it holds CIN: U74999DL2018PTC328076. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Manisha Majhi (Director), Paresh Kumar Panda (Director). Its latest AGM occurred on 27 September 2023, with the balance sheet filed on 31 March 2023. It is based at Shop No F-2, Plot No - 4, Falcon Plaza Pkt - 7, Sec - 12, Dwarka Ist Floor, Dwarka, Delhi, 110078.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999DL2018PTC328076

  • Registration Number

    328076

  • Incorporation Date

    05 January 2018

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 8 Year, 1 Month
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth **** -73.80%
  • Profit Growth **** -84.40%
  • Ebitda **** 1192.37%
  • Net Worth 1.22%
  • Total Assets -6.74%
Company report

Sieger Therapeutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sieger Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Sieger Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Manisha Majhi Director 05 Jan 2018 Current
Paresh Kumar Panda Director 05 Jan 2018 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sieger Therapeutics.

Sieger Therapeutics Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 73.8% decrease. The company also saw a substantial fall in profitability, with a 84.4% decrease in profit. The company's net worth moved up by a moderate rise of 1.22%.

Sieger Therapeutics revenue growth over time
Sieger Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
-73.80%
*******
*******
*******
*******
Revenue from Operations
*******
-73.80%
*******
*******
*******
*******
Total Assets
*******
-6.74%
*******
*******
*******
*******
Profit or Loss
*******
-84.40%
*******
*******
*******
*******
Net Worth
*******
1.22%
*******
*******
*******
*******
EBITDA
*******
1192.37%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sieger Therapeutics?

Unlock access to Sieger Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sieger Therapeutics?

Unlock and access historical data on people associated with Sieger Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sieger Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sieger Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sieger Therapeutics
Recent Activity within the Organization
  • Annual General Meeting

    Sieger Therapeutics Private Limited last Annual general meeting of members was held on 27 Sep 2023 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Sieger Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    The activity Manisha Majhi was appointed as a Director was appointed as a Director on 05 Jan 2018 & has been associated with this company since 8 years 1 month . was completed.

  • Director Appointment

    The activity Paresh Kumar Panda was appointed as a Director was appointed as a Director on 05 Jan 2018 & has been associated with this company since 8 years 1 month . was completed.

  • Company Incorporation

    Progress on Sieger Therapeutics Private Limited was registered on 05 Jan 2018 with Roc Delhi & aged 8 years 1 month as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sieger Therapeutics Private Limited?

The CIN of Sieger Therapeutics Private Limited is U74999DL2018PTC328076.

Where is Sieger Therapeutics Private Limited headquartered?

Sieger Therapeutics Private Limited is headquartered at Shop No F-2, Plot No - 4, Falcon Plaza Pkt - 7, Sec - 12, Dwarka Ist Floor, Dwarka, Delhi, 110078.

When was Sieger Therapeutics Private Limited incorporated?

Sieger Therapeutics Private Limited was incorporated on 05 January 2018.

Who are the current directors of Sieger Therapeutics Private Limited?

The current directors of Sieger Therapeutics Private Limited are

What is the primary industry of Sieger Therapeutics Private Limited?

The primary industry of Sieger Therapeutics Private Limited is Business Services.

Is Sieger Therapeutics Private Limited a listed company?

Sieger Therapeutics Private Limited is unlisted.

What is the capital structure of Sieger Therapeutics Private Limited?

The authorized capital of Sieger Therapeutics Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available